This inventor holds 4 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Intrexon Corporation. Active years: 2011-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2020
Title: Innovations of Inventor Bing Li
Introduction
Bing Li is a notable inventor based in Shrewsbury, MA (US), recognized for his contributions to the field of gene expression modulation. With a total of four patents to his name, he has made significant strides in the development of innovative technologies that have the potential to impact various scientific applications.
Latest Patents
One of his latest patents is titled "Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex." This invention provides diacylhydrazine ligands and chiral diacylhydrazine ligands for use with ecdysone receptor-based inducible gene expression systems. The applications of this invention are vast, including gene therapy, large-scale production of proteins and antibodies, cell-based screening assays, functional genomics, proteomics, metabolomics, and the regulation of traits in transgenic organisms. An advantage of this invention is that it allows for the regulation of gene expression and the tailoring of expression levels to meet specific user requirements.
Career Highlights
Bing Li has worked with prominent companies in the biotechnology sector, including Intrexon Corporation and Precigen, Inc. His experience in these organizations has contributed to his expertise and innovation in the field.
Collaborations
One of his notable collaborators is Robert Eugene Hormann, with whom he has worked on various projects related to his patents.
Conclusion
Bing Li's work in the field of gene expression modulation showcases his innovative spirit and dedication to advancing scientific research. His patents reflect a commitment to developing technologies that can significantly benefit various applications in biotechnology and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
